Amoroso Michael 4

What Happened
Michael Amoroso, a director of Abeona Therapeutics, received a grant of 37,313 restricted common shares on January 26, 2026. The shares were reported as acquired at $0.00 (an award/compensation grant), so there was no cash payment recorded in the Form 4.

Key Details

• Transaction date: January 26, 2026; Form 4 filed January 27, 2026 (timely; Form 4s are due within two business days).
• Transaction type: Award/Grant (Form 4 code "A"); 37,313 shares granted at $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: All of the restricted stock will vest on January 26, 2027.
• No indication of a 10b5-1 plan, tax withholding, or immediate sale in this filing.

Context
Restricted stock awards are commonly used as part of director or executive compensation and typically vest over time; they do not necessarily signal a personal buying or selling decision. Because these shares are subject to a one-year vesting condition, the recipient cannot freely sell them until they vest (unless otherwise specified). This grant reflects compensation rather than an open-market purchase or sale.